Host-directed therapy for tuberculosis: Repurposed drugs toward global tuberculosis elimination.
- 2026-06
- Review
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 167
- Yi Hao Wong
- Hai Tarng Chong
- Ting Huey Hu
- Catherine Wei Min Ong
- PubMed: 41856464
- DOI: 10.1016/j.ijid.2026.108545
- Low evidence
This review synthesizes the mechanistic and clinical evidence supporting repurposed, affordable agents for use in high TB-burden, resource-limited settings. We categorize the HDT candidates by their targeted host pathways, including autophagy (metformin, vitamin D, all-trans retinoic acid), inflammatory signaling (nonsteroidal anti-inflammatory drugs), immunomodulation (corticosteroids), matrix metalloproteinase inhibition (doxycycline), lipid metabolism (statins, PSCK9 inhibitors), tumor necrosis factor-⍺ inhibitors (adalimumab, infliximab), redox homeostasis (glutathione, N-acetylcysteine), and immunothrombosis.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes